PTPRE and osteoporosis: In the PTPRE gene drug binding domain for alendronate (indicated for osteoporosis) (Supplementary Table 11), we identify a variant (chr10:129868686) in Roma (3.7%), virtually absent in non-Roma, except GIH (0.5%) (Supplementary Table 11).